Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Dingdang Health Technology Group PB Ratio?
Dingdang Health Technology GroupHKSE:09886 68 PB Ratio is 0.58 as of Aug. 27, 2026, which is 18% below its 10-year median of 0.71. GuruFocus rates HKSE:09886 with a GF Score™ of 68/100 and a GF Value™ of HK$1.44 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 612 Healthcare Providers & Services companies, Dingdang Health Technology Group ranks better than 90.69% on this metric.
HKSE:09886'
s PB Ratio Range Over the Past 10 Years
Min: 0.25 Med: 0.71 Max: 6.58
Current: 0.59
During the past 8 years, Dingdang Health Technology Group's highest PB Ratio was 6.58. The lowest was 0.25. And the median was 0.71.
HKSE:09886's PB Ratio is ranked better than 90.69% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs HKSE:09886: 0.59
During the past 12 months, Dingdang Health Technology Group's average Book Value Per Share Growth Rate was 4.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -8.30% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Dingdang Health Technology Group was -8.30% per year. The lowest was -154.90% per year. And the median was -81.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Dingdang Health Technology Group PB Ratio Related Terms
Dingdang Health Technology Group PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:09886 vs VEEV, BTSG, HQY: PB Ratio Comparison
For the Health Information Services subindustry, Dingdang Health Technology Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dingdang Health Technology Group PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dingdang Health Technology Group's PB Ratio falls into.
Dingdang Health Technology Group PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dingdang Health Technology Group (HKSE:09886) has a PB Ratio of 0.58 as of Aug. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dingdang Health Technology Group and its competitors. This is 18% below median its historical median of 0.71. Over the past decade, Dingdang Health Technology Group's PB Ratio has ranged from 0.25 to 6.58. According to the industry distribution chart, Dingdang Health Technology Group ranks #57 out of 612 companies in the Healthcare Providers & Services industry, placing it in the top 9.3%.
Is Dingdang Health Technology Group's PB Ratio too high?
Dingdang Health Technology Group's current PB Ratio of 0.58 is 18% below median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 6.58. The Healthcare Providers & Services industry median PB Ratio is 1.98. Dingdang Health Technology Group's value of 0.58 is 70.7% below this industry median. Based on the distribution chart, Dingdang Health Technology Group ranks #57 out of 612 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dingdang Health Technology Group has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dingdang Health Technology Group's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Dingdang Health Technology Group ranks #57 out of 612 companies for PB Ratio. This places Dingdang Health Technology Group in the top 9% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. Dingdang Health Technology Group's value of 0.58 is 70.7% below this benchmark. Historically, Dingdang Health Technology Group's own PB Ratio has ranged from 0.25 to 6.58 over the past decade. While the company's 10-year median is 0.71 vs. the industry median of 1.98, Dingdang Health Technology Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dingdang Health Technology Group's current PB Ratio of 0.58 is 70.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dingdang Health Technology Group and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dingdang Health Technology Group's current PB Ratio is 0.58, which is 18% below median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dingdang Health Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dingdang Health Technology Group (HKSE:09886) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.44, compared to a current price of HK$0.82 — trading 43.1% below its estimated fair value. The current PB Ratio is 0.58, which is 18% below median its 10-year median of 0.71 and 70.7% below the Healthcare Providers & Services industry median of 1.98. Dingdang Health Technology Group's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dingdang Health Technology Group (HKSE:09886), the current PB Ratio is 0.58 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dingdang Health Technology Group (HKSE:09886) Overvalued in 2026?
Based on GuruFocus' analysis, Dingdang Health Technology Group stock appears to be undervalued.
The current stock price of HK$0.82 is trading 43.1% below its estimated GF Value™ of HK$1.44.
GuruFocus considers Dingdang Health Technology Group to be Possible Value Trap.
Key valuation signals for HKSE:09886:
PB Ratio: 0.58 (18% below median its 10-year median of 0.71)
GF Value™: HK$1.44 vs. price of HK$0.82 (43.1% below fair value)
Industry Position: 70.7% below the Healthcare Providers & Services median (#57 of 612)
No single metric tells the full story. See the HKSE:09886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions. All of the company's revenue is generated from the PRC.
68GF Score
Get the complete analysis for HKSE:09886
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09886 has been successfully added to your 
